Adding the numbers, since they settle part of this. With resmetirom now available for MASH, combination approaches are being explored, so the standard of care in this area is moving faster than most threads assume.
That is the short version; the long version is somebody else's post.
One thing that is still open after Dr.SleepRoch’s answer:
Whether normalised enzymes tell you anything about fibrosis, and what the right follow-up measurement is?
raj_cambridge said:With resmetirom now available for MASH, combination approaches are being explored, so the standard of care in this area is moving faster than most…
Coming at raj_cambridge’s question from a different direction. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsOP back with an update, since a thread like this is useless without one.
Closing the loop. The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.
Dr.SurgeonPGH said:It helps to say which part of this you are uncertain about.
True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.